pseudallescheria
boydii
fungal
organ
known
affect
immunocompromis
patient
organ
known
caus
sever
case
invas
infect
variou
organ
central
nervou
cardiovascular
respiratori
system
report
unusu
case
pulmonari
p
boydii
pneumonia
immunocompromis
critic
ill
patient
coinfect
aspergillu
fumigatu
aspergillu
terreu
ard
case
highlight
import
high
index
suspicion
superimpos
fungal
infect
patient
critic
ill
immunocompromis
uncommon
fungal
pathogen
consid
differenti
diagnosi
respiratori
failur
especi
diagnost
marker
galactomannan
bal
serum
elev
diagnost
intervent
warrant
insuffici
clinic
improv
observ
prevent
treatment
failur
advers
outcom
pseudallescheria
boydii
fungal
organ
known
affect
immunocompromis
patient
organ
soil
water
natur
inhabit
known
caus
madura
foot
sever
case
invas
infect
variou
organ
central
nervou
cardiovascular
respiratori
system
report
unusu
case
pulmonari
p
boydii
pneumonia
immunocompromis
critic
ill
patient
coinfect
aspergillu
fumigatu
aspergillu
terreu
ard
case
highlight
import
includ
uncommon
fungal
pathogen
differenti
diagnosi
critic
ill
hematopoiet
stem
cell
recipi
respiratori
failur
male
patient
admit
intens
care
unit
acut
respiratori
failur
day
patient
receiv
highdosag
chemotherapi
melphalan
follow
autolog
hematopoiet
stem
cell
transplant
histori
multipl
myeloma
admiss
patient
afebril
neutropen
elev
respiratori
rate
l
oxygen
oxygen
satur
blood
pressur
hypotens
mmhg
heart
rate
elev
bpm
laboratori
find
demonstr
elev
procalcitonin
level
ngml
ngml
creactiv
protein
mgdl
mgdl
leukocyt
count
gl
gl
furthermor
patient
present
acut
kidney
injuri
anuria
within
hour
patient
develop
septic
shock
intub
highdosag
norepinephrin
therapi
necessari
besid
bronchoscopi
bronchoalveolar
lavag
bal
standard
microbiolog
test
galactomannan
bal
well
serum
addit
test
perform
see
tabl
initi
antibiot
regim
normal
ward
meropenem
linezolid
clarithromycin
antimycot
therapi
liposom
amphotericin
b
continu
within
anoth
h
later
patient
develop
sever
acut
respiratori
distress
syndrom
ard
make
ecmo
extracorpor
membran
oxygen
necessari
refer
find
tabl
initi
antibiot
regim
expand
oseltamivir
ribavirin
influenza
b
respiratori
syncyti
viru
respect
new
find
aspergillu
terreu
p
boydii
antimycot
therapi
switch
voriconazol
howev
day
patient
die
due
ard
autopsi
deni
patient
testament
pseudallescheria
boydii
asexu
anamorph
scedosporium
ubiquit
filament
fungi
found
soil
water
sewag
frequent
pathogen
neardrown
victim
especi
area
p
boydii
endem
organ
septat
thinwal
branch
hypha
angioinvas
tendenc
clinic
p
boydii
infect
insidi
onset
often
fatal
immunocompromis
host
report
case
spectrum
pulmonari
diseas
caus
p
boydii
remark
similar
due
aspergillu
infect
includ
allerg
bronchopulmonari
pseudallescheriasi
pseudallescherioma
pneumonia
invas
infect
central
nervou
system
abscess
rhinosinus
endophthalm
pneumonia
skin
lesion
madura
foot
may
present
aspergillu
tracheobronch
report
commonli
patient
hematolog
malign
seen
patient
recipi
solid
organ
transplant
patient
hiv
infect
diagnosi
p
boydii
aspergillu
spp
challeng
clinic
find
tomograph
imag
nonspecif
seen
case
import
p
boydii
differenti
aspergillu
spp
invas
infect
caus
member
fumigatu
speci
complex
report
infect
transplant
chest
ct
abnorm
may
display
pulmonari
cavit
noncavitari
mass
treeinbud
nodul
groundglass
opac
bronchial
thicken
mediastin
lymphadenopathi
cultur
organ
combin
evid
tissu
invas
histopatholog
cultur
normal
steril
site
provid
certain
evid
histopatholog
diagnosi
p
boydii
may
confus
aspergillu
form
colorless
septat
hypha
dichotom
branch
hyalohyphomycos
histopatholog
find
septat
branch
hyalin
hypha
similar
aspergillosi
direct
microscopi
furthermor
perform
biopsi
feasibl
patient
due
bleed
risk
risk
complic
situat
patient
outrag
thrombocytopenia
patient
risk
factor
clinic
andor
radiograph
featur
suggest
invas
aspergillosi
cultur
aspergillu
spp
respiratori
secret
provid
adequ
evid
invas
diseas
aspergillu
rapidli
grow
fungu
laboratori
often
visibl
cultur
within
day
incub
howev
identif
speci
requir
sporul
order
microscop
examin
sporebear
structur
posit
predict
valu
highest
bal
cultur
depend
upon
host
clinic
present
studi
evalu
predict
valu
lower
respiratori
tract
cultur
differ
patient
popul
probabl
proven
invas
pulmonari
aspergillosi
posit
predict
valu
highest
hematopoiet
cell
transplant
recipi
patient
hematolog
malign
granulocytopen
patient
contrast
rang
diagnost
molecular
method
panfung
multiplex
pcr
employ
diagnos
p
boydii
yet
valid
use
adjunct
convent
laboratori
test
particularli
within
p
boydii
complex
identif
complic
low
interspeci
divers
high
intraspeci
variabl
howev
galactomannan
polysaccharid
major
constitu
aspergillu
spp
cell
wall
highli
specif
react
antigen
aspergillu
spp
antigen
larg
number
clinic
import
fungi
includ
candida
speci
cryptococcu
neoforman
fusarium
solani
penicillium
marneffei
p
boydii
report
case
even
recent
assay
use
doublesandwich
enzym
immunoassay
eia
higher
sensit
avail
use
serum
sampl
adjunct
test
diagnosi
aspergillosi
galactomannan
eia
perform
optic
readout
interpret
ratio
rel
optic
densiti
od
threshold
control
provid
manufactur
call
od
index
assay
suggest
threshold
od
index
thu
od
index
consid
posit
result
report
patient
index
combin
proven
probabl
case
sensit
specif
ci
ci
respect
subgroup
analys
suggest
assay
perform
better
patient
hematolog
malign
receiv
hematopoiet
cell
transplant
report
case
galactomannan
eia
detect
fungal
antigen
even
organ
grow
laboratori
provid
indic
potenti
invas
diseas
galactomannan
eia
perform
bal
fluid
provid
addit
sensit
compar
cultur
estim
studi
exceed
specif
wherea
od
index
threshold
result
sensit
specif
seen
patient
od
index
highli
elev
note
od
index
posit
galactomannan
eia
serum
bal
fluid
anoth
cell
wall
compon
mani
fungi
detect
betadglucan
assay
output
serum
assay
current
base
spectrophotomet
read
optic
densiti
convert
betadglucan
concentr
result
interpret
neg
rang
pg
ml
indetermin
pgml
posit
pgml
patient
betadglucan
level
pgml
importantli
cutoff
defin
clinic
context
identifi
breakthrough
invas
fungal
infect
primarili
invas
candidiasi
peopl
undergo
treatment
hematolog
malign
report
massiv
elev
betadglucan
level
precis
cutoff
optim
perform
assay
aid
diagnos
invas
aspergillosi
defin
may
differ
metaanalysi
includ
six
cohort
studi
patient
hematolog
malign
note
lower
sensit
ci
higher
specif
ci
probabl
invas
aspergillosi
previous
report
despit
substanti
heterogen
among
differ
studi
betadglucan
assay
good
accuraci
distinguish
patient
proven
probabl
invas
fungal
infect
patient
without
invas
fungal
infect
betadglucan
assay
may
use
detect
invas
fungal
infect
earli
cours
infect
prior
onset
overt
clinic
find
although
best
result
use
assay
diagnos
invas
candidiasi
aspergillosi
also
small
report
detect
uncommon
fungal
diseas
scedosporium
spp
anoth
import
point
isol
fungu
variabl
suscept
fungi
amphotericin
b
antifung
agent
fungi
p
boydii
terreu
show
resist
amphotericin
b
sensit
azol
drug
antifung
treatment
vari
accord
immunolog
statu
voriconazol
mainstay
treatment
immunocompromis
host
p
boydii
gener
sensit
azol
variou
report
indic
intrins
p
boydii
resist
polyen
moreov
optimum
durat
treatment
unknown
case
highlight
import
high
index
suspicion
superimpos
fungal
infect
patient
critic
ill
immunocompromis
uncommon
fungal
pathogen
consid
differenti
diagnosi
respiratori
failur
especi
diagnost
marker
elev
diagnost
intervent
warrant
insuffici
clinic
improv
observ
prevent
treatment
failur
advers
outcom
